| scholarly article | Q13442814 |
| P356 | DOI | 10.1046/J.1526-4610.42.S2.5.X |
| P698 | PubMed publication ID | 12028323 |
| P2093 | author name string | Robert Ryan | |
| Jerome Goldstein | |||
| Alan Rapoport | |||
| Charlotte Keywood | |||
| P2860 | cites work | Pharmacokinetics and pharmacodynamics of the triptan antimigraine agents: a comparative review | Q34235325 |
| Frovatriptan: a review of drug-drug interactions | Q34655559 | ||
| Efficacy of naratriptan tablets in the acute treatment of migraine: a dose-ranging study. Naratriptan S2WB2004 Study Group | Q39426985 | ||
| Tolerability and efficacy of naratriptan tablets with long-term treatment (6 months). Naratriptan Long-term Study Group | Q39447979 | ||
| Efficacy and safety of sumatriptan tablets (25 mg, 50 mg, and 100 mg) in the acute treatment of migraine: defining the optimum doses of oral sumatriptan | Q39448906 | ||
| Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, parallel-group study. Naratriptan S2WA3001 Study Group | Q39451379 | ||
| Optimizing the dose of zolmitriptan (Zomig, 311C90) for the acute treatment of migraine. A multicenter, double-blind, placebo-controlled, dose range-finding study. The 017 Clinical Trial Study Group | Q39452008 | ||
| Effects of the novel high-affinity 5-HT(1B/1D)-receptor ligand frovatriptan in human isolated basilar and coronary arteries | Q47698318 | ||
| P921 | main subject | migraine | Q133823 |
| P304 | page(s) | S74-83 | |
| P577 | publication date | 2002-04-01 | |
| P1433 | published in | Headache | Q5689497 |
| P1476 | title | Dose range-finding studies with frovatriptan in the acute treatment of migraine | |
| P478 | volume | 42 Suppl 2 |
| Q27025002 | A review of frovatriptan for the treatment of menstrual migraine |
| Q37798757 | Are the current IHS guidelines for migraine drug trials being followed? |
| Q44004697 | Clinical efficacy of frovatriptan: placebo-controlled studies |
| Q38927015 | Comparative tolerability of treatments for acute migraine: A network meta-analysis |
| Q38378898 | Drug safety in acute migraine treatment. |
| Q36335025 | Efficacy and tolerability of frovatriptan in acute migraine treatment: systematic review of randomized controlled trials |
| Q37427358 | Frovatriptan and rizatriptan economic EVAluation: the FREEVA study |
| Q33775913 | Frovatriptan is Effective and Well Tolerated in Korean Migraineurs: A Double-Blind, Randomized, Placebo-Controlled Trial |
| Q37000753 | Frovatriptan review |
| Q38035403 | Frovatriptan: a review of its use in the acute treatment of migraine |
| Q27002977 | Managing migraine by patient profile: role of frovatriptan |
| Q34691359 | Marketed oral triptans in the acute treatment of migraine: a systematic review on efficacy and tolerability |
| Q37847067 | Optimal balance of efficacy and tolerability of oral triptans and telcagepant: a review and a clinical comment |
| Q37935031 | Pharmacokinetic evaluation of frovatriptan |
| Q45040981 | Pharmacokinetics of frovatriptan in adolescent migraineurs |
| Q46051440 | Pharmacokinetics of two 6-day frovatriptan dosing regimens used for the short-term prevention of menstrual migraine: A phase I, randomized, double-blind, placebo-controlled, two-period crossover, single-centre study in healthy female volunteers |
| Q38533414 | Review of dose-response curves for acute antimigraine drugs: triptans, 5-HT1F agonists and CGRP antagonists |
| Q36836794 | Review of frovatriptan in the treatment of migraine |
| Q38323922 | The acute treatment of migraine in adults: the american headache society evidence assessment of migraine pharmacotherapies |
| Q39983756 | The triptans |
| Q34129854 | Triptans for the management of migraine |
| Q46955158 | Triptans in the treatment of migraine: drug selection by means of the SOJA method |
| Q48514146 | Two center, randomized pilot study of migraine prophylaxis comparing paradigms using pre-emptive frovatriptan or daily topiramate: research and clinical implications |
Search more.